FARA General Research Grant
Supports Friedreich's ataxia science across discovery, preclinical work, and clinical pathways with competitive project funding.
The FARA General Research Grant is Friedreich's Ataxia Research Alliance's main competitive route for work on Friedreich's ataxia, covering basic science, translational development, and clinical research. It sits under FARA's disease-focused research portfolio and is meant to move FA projects toward therapeutic progress. Awards reach up to $125,000 per year for one to two years, with two cycles each year and a letter of intent required before full application. FARA does not fund indirect costs through this mechanism, travel is capped at $3,000 per year, and investigators at any career stage and from any country may compete, so the door stays open to established labs and newer teams alike. The strongest applications align clearly with FARA's priority areas: neuroscience, cardiac disease, the molecular basis of FA, drug discovery, translational facilitation, and clinical research. Teams tend to fare best when the proposal is focused, mechanistically grounded, and built around a realistic path to therapeutic relevance, with the letter of intent used to show fit early.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.